Breathing therapy for patients with medically unexplained physical symptoms and dysfunctional breathing: A pilot and feasibility trial
PLOS One · 2025
DOI: 10.1371/journal.pone.0325951 ↗Kurz gefasst
Klinische Studie in der Zeitschrift PLOS One, 2025. Verfasst von Hege Svenningsen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Lege Hege Svenningsen AS, Norway. Hauptthemen laut MEDLINE: Breathing Exercises, Medically Unexplained Symptoms, Respiratory Therapy, Respiration Disorders. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aust-Agder Utviklings- og Kompetansefond.
Abstract (Originalsprache)
Medically unexplained physical symptoms (MUPS) are symptoms without an identifiable organic cause that lead to functional impairment. MUPS is highly prevalent in general practice consultations. This pilot trial aimed to investigate the effectiveness and feasibility of a 5-week breathing retraining program focusing on basic anatomy and physiology, breathing awareness, nasal breathing and resonance (coherent) breathing for patients meeting the criteria for MUPS. The trial used a quantitative design with pre- and post-intervention measurements. Fifteen participants with MUPS and dysfunctional breathing (assessed by the Nijmegen Questionnaire) were recruited from two general practitioner offices. The intervention consisted of 5 weekly sessions including education on breathing physiology and weekly breathing exercises focused on nasal breathing and resonance breathing techniques. One week post intervention, improvements were observed in dysfunctional breathing scores, lower symptom severity, higher general well-being, and reduced musculoskeletal pain complaints. At 3 months post-intervention, sustained improvements were seen in dysfunctional breathing, general well-being, musculoskeletal pain, and additionally lower pseudoneurological, gastrointestinal, and allergy complaints, as well as lower overall symptom burden and improved end-tidal CO 2 levels. The trial concluded that the 5-week breathing program showed promising results for improving multiple patient-reported outcomes in MUPS. Recruitment, adherence, and acceptability of the program were satisfactory. A randomized controlled trial is recommended to further evaluate the efficacy of this breathing intervention for MUPS patients. Trial registration: ClinicalTrials.gov NCT06575920
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Lege Hege Svenningsen AS, Norway.
- UiT The Arctic University of Norway, Department of Community Medicine, Faculty of Health Science, Norway.
- Southern Cross University, Lismore, New South Wales, Australia.
- University of Agder, Department of health and nursing, Norway.
ORCID-Profile: Hege Svenningsen, Rosalba Courtney
Förderung
- Aust-Agder Utviklings- og Kompetansefond
Zitieren
APA
Svenningsen, H., Stub, T., Courtney, R., & Karlsen, T. I. (2025). Breathing therapy for patients with medically unexplained physical symptoms and dysfunctional breathing: A pilot and feasibility trial. PLOS One. https://doi.org/10.1371/journal.pone.0325951
Vancouver
Svenningsen H, Stub T, Courtney R, Karlsen TI. Breathing therapy for patients with medically unexplained physical symptoms and dysfunctional breathing: A pilot and feasibility trial. PLOS One. 2025. doi:10.1371/journal.pone.0325951
BibTeX
@article{Svenningsen2025,
author = {Svenningsen, Hege and Stub, Trine and Courtney, Rosalba and Karlsen, Tor-Ivar},
title = {Breathing therapy for patients with medically unexplained physical symptoms and dysfunctional breathing: A pilot and feasibility trial},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0325951}
}
EUVIMED